Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIFU for Allergic Rhinitis
NCT06272032Phase 1Recruiting
- Sponsor
- Chongqing Medical University
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Chongqing Medical University. Primary endpoints: Nasal Symptom Score at 2 years and Daily Medication Score at 2 years. Started Aug 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06272032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06272032.